Latest Articles

Publication Date
All News Scientific
ASCO 2025: Key Highlights in Endometrial and Related Cancers - Medscape

ASCO 2025: Key Highlights in Endometrial and Related Cancers Medscape

Published: June 9, 2025, 9:21 p.m.
Read Full Article
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as Fir - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as Fir GuruFocus

Published: June 9, 2025, 7:13 p.m.
Read Full Article
High-flying doctor to LA stars Khloe Kardashian and Hailey Bieber reveals her new calling in life - Daily Mail

High-flying doctor to LA stars Khloe Kardashian and Hailey Bieber reveals her new calling in life Daily Mail

Published: June 9, 2025, 5:07 p.m.
Read Full Article
Leveraging epigenetic aberrations in the pathogenesis of endometriosis: From DNA methylation to non-coding RNAs - Frontiers

Leveraging epigenetic aberrations in the pathogenesis of endometriosis: From DNA methylation to non-coding RNAs Frontiers

Published: June 9, 2025, 4:59 p.m.
Read Full Article
Bindi Irwin Shared the First Thing Daughter Grace Did When She Got Home From Disneyland & It’s Classic Irwin - SheKnows

Bindi Irwin Shared the First Thing Daughter Grace Did When She Got Home From Disneyland & It’s Classic Irwin SheKnows

Published: June 9, 2025, 2:21 p.m.
Read Full Article
AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News - GuruFocus

AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:46 p.m.
Read Full Article
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer BioSpace

Published: June 9, 2025, 12:43 p.m.
Read Full Article
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:18 p.m.
Read Full Article
Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News - Stock Titan

Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News Stock Titan

Published: June 9, 2025, noon
Read Full Article
Women Health: 7 sience backed facts about PCOS and Endometriosis every woman should know - Asianet Newsable

Women Health: 7 sience backed facts about PCOS and Endometriosis every woman should know Asianet Newsable

Published: June 7, 2025, 1:35 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!